DRY SKIN AS AN AUXILIARY DIAGNOSTIC CRITERION FOR ATOPIC DERMATITIS. EXPERIENCE IN EFFECTIVELY USING ECTOIN-CONTAINING EXTERNAL AGENT IN CHILDHOOD

DOI: https://doi.org/10.29296/25877305-2019-03-06
Download full text PDF
Issue: 
3
Year: 
2019

Professor A. Kudryavtseva, MD; R. Mingaliev I.M. Sechenov First Moscow State Medical University (Sechenov University)

Atopic dermatitis (AtD) is a chronic inflammatory skin disease, the basis for the pathogenesis of which is an incompetent skin barrier with an immune system imbalance. The skin forms mechanical and immune barriers that protect the body from aggressive environmental factors. Innate immunity imbalance leads to skin infection with opportunistic bacteria that maintain the local inflammatory process. Dry skin is now considered as an auxiliary criterion for AtD. Some experts are ready to include this factor for the progression of AtD in a set of its main criteria. The paper considers the experience with the new cream, the main component of which is the ectoin molecule at a concentration of 7%. There has been recently a noticeable increase in the number of works dealing with different therapeutic and prophylactic properties of ectoines, which are useful in medicine and cosmetology. Ectoin used as part of the agent to relieve inflammatory reactions in allergies and AtD has a certain positive effect. Skin hydration control along with anti-inflammatory therapy can contribute to reducing the risk of more severe forms of the disease, by maintaining the achieved remission of AtD.

Keywords: 
dermatology
atopic dermatitis
skin barrier
dry skin
skin moistening
ectoin



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Noh Y., Lee J., Seo S. et al. Promoter DNA methylation contributes to human β-defensin-1 deficiency in atopic dermatitis // Anim. Cells Syst. (Seoul). – 2018; 22 (3): 172–7. DOI: 10.1080/19768354.2018.1458652.
  2. Hassani B., Isaian A., Shariat M. et al. Filaggrin gene polymorphisms in Iranian ichthyosis vulgaris and atopic dermatitis patients // Int. J. Dermatol. – 2018; 57 (12): 1485–91. DOI:10.1111/ijd.14213.
  3. Yang E., Beck K., Sekhon S. et al. The impact of pediatric atopic dermatitis on families: A review // Pediatr. Dermatol. – 2019; 36 (1): 66–71. DOI: 10.1111/pde.13727.
  4. Fluer F.S., Kudrjavtseva A.V., Neskorodova K.A. i dr. Vyrabotka enterotoksinov A, B, C i toksinov s sindromom toksicheskogo shoka razlichnymi vidami stafilokokkov, vydelennyh iz kozhi detej s atopicheskim dermatitom // Pediatria. – 2017; 96 (6): 87–91 [Fluer F.S.Kudryavtseva A.V.Neskorodova K.A. et al. Production of enterotoxins A, B, C and toxin of toxic shock syndrome by various types of staphylococci extracted from the skin of children with atopic dermatitis // Pediatria. – 2017; 96 (6): 87–91 (in Russ.)].
  5. Baviera G., Maiello N., Galli E. Staphylococcus aureus and atopic dermatitis: which came first, the chicken or the egg? // EMJ Dermatol. – 2015; 1 (3): 92–7.
  6. Kudrjavtseva A.V., Morozova O.A. Kolonizatsija stafilokokkom kozhnyh pokrovov detej s atopicheskim dermatitom kak kriterij effektivnosti naruzhnogo lechenija // Prakticheskaja meditsina. – 2012; 65 (9): 284–7 [Kudryavtseva A.V., Morozova O.A. Kolonizatsiya stafilokokkom kozhnykh pokrovov detei s atopicheskim dermatitom kak kriterii effektivnosti naruzhnogo lecheniya // Prakticheskaya meditsina. – 2012; 65 (9): 284–7 (in Russ.)].
  7. Kudrjavtseva A.V. Narushenie kozhnogo bar'era kak veduschij faktor formirovanija mestnogo vospalitel'nogo protsessa pri atopicheskom dermatite // Vestn. dermatol. i venerol. – 2017; 4: 82–9 [Kudryavtseva A.V. Breach of skin barrier as a leading factor in the formation of local inflammatory process in atopic dermatitis // Vestnik dermatologii i venerologii. – 2017; 4: 82–9 (in Russ.)]. https://doi.org/10.25208/0042-4609-2017-0-4-62-77.
  8. Czarnowicki T., Krueger J., Guttman-Yassky E. Skin Barrier and Immune Dysregulation in Atopic Dermatitis: An Evolving Story with Important Clinical Implications // J. Allergy Clin. Immunol. Pract. – 2014; 4 (2): 371–9.
  9. Benedetto A., Atopic Dermatitis: A Disease Caused by Innate Immune Defects? // J. Invest. Dermatol. – 2009; 1 (129): 14–30.
  10. Howell M., Cathelicidin Deficiency Predisposes to Eczema Herpeticum // J. Allergy Clin. Immunol. – 2006; 4 (117): 836–41.
  11. Ong P. Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis // N. Engl. J. Med. – 2002; 15 (347): 1151–60.
  12. Travers J., Norris D., Leung D. The Keratinocyte as a Target for Staphylococcal Bacterial Toxins // J. Investig. Dermatol. Symp. Proc. – 2001; 3 (6): 225–30.
  13. Warner J., McGirt L., Beck L. Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis // Br. J. Dermatol. – 2009; 1 (160): 183–5.
  14. Peng W., Jenneck C., Bussmann C. et al. Risk Factors of Atopic Dermatitis Patients for Eczema Herpeticum // J. Invest. Dermatol. – 2007; 5 (127): 1261–3.
  15. Ohshima M., Miyake M., Takeda M. et al. Staphylococcal Enterotoxin B Causes Proliferation of Sensory C-Fibers and Subsequent Enhancement of Neurogenic Inflammation in Rat Skin // J. Infect. Dis. – 2011; 6 (203): 862–9.
  16. Elias P., Wakefield J. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in atopic dermatitis // J. Allergy Clin. Immunol. – 2014; 4 (134): 781–91.
  17. Irvine A., McLean W., Leung D. Filaggrin Mutations Associated with Skin and Allergic Diseases // N. Engl. J. Med. – 2011; 14 (365): 1315–27.
  18. O’Regan G. Filaggrin in atopic dermatitis // J. Allergy Clin. Immunol. – 2008; 4 (122): 689–93
  19. Henderson J., Northstone K., Lee S. et al. The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort study // J. Allergy Clin. Immunol. – 2008; 4 (121): 872–7.
  20. Suárez-Fariñas M., Tintle S., Shemer A. et. al. Non-lesional atopic dermatitis (AD) skin is characterized by broad terminal differentiation defects and variable immune abnormalities // J. Allergy Clin. Immunol. – 2011; 4 (127): 954–64.
  21. Novak N. An update on the role of human dendritic cells in patients with atopic dermatitis // J. Allergy Clin. Immunol. – 2012; 4 (129): 879–86.
  22. Garg N., Silverberg J. Epidemiology of childhood atopic dermatitis // Clin. Dermatol. – 2015; 33 (3): 281–8.
  23. Vakharia P., Chopra R., Silverberg J. Systematic Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized Controlled Trials // Am. J. Clin. Dermatol. – 2018; 19 (1): 15–22. DOI: 10.1007/s40257-017-0299-4.
  24. Hanifin J., Rajka G. Diagnostic features of atopic eczema // Acta Dermato-Venereol. – 1980; 92: 44–7.
  25. Johansson S., Bieber T., Dahl R. et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 // J. Allergy Clin. Immunol. – 2004; 113 (5): 832–6. DOI: 10.1016/j.jaci.2003.12.591 .
  26. Atopicheskij dermatit u detej. Klinicheskie rekomendatsii [Atopicheskii dermatit u detei. Klinicheskie rekomendatsii (in Russ.)]. https://www.pediatr-russia.ru/sites/default/files/file/kr_ad.pdf
  27. Food Allergy and Anaphylaxis Guidelines / EAACI, 2014; 278 p.
  28. Brenninkmeijer E., Schram M., Leeflang M. et al. Diagnostic criteria for atopic dermatitis: a systematic review // Br. J. Dermatol. – 2009; 158 (4): 754–65. DOI: 10.1111/j.1365-2133.2007.08412.x.
  29. Andersen R., Thyssen J., Maibach H. Qualitative vs. quantitative atopic dermatitis criteria: in historical and present perspectives // J. Eur. Acad. Dermatol. Venereol. – 2016; 30 (4): 604–18.
  30. Scientific Information: Ectoin the natural stress-protecting molecule / Bitop AG, Germany, 44 p. http://www.ectoin.net/data/download/bitop_basisbroschuere.pdf